VITH INTERNATIONAL CONGRESS: INBORN ERRORS OF METABOLISM

遗传性代谢紊乱现在被认为是 越来越多的严重临床疾病， 智力发育和各种眼科，神经肌肉， 心脏、肺、肝、肾、关节炎和糖尿病 表现。 对尽可能多的美国调查人员来说， 参加即将举行的国际会议，因为 在理解生物学的分子基础方面取得了前所未有的进展， 遗传性代谢紊乱和令人兴奋的前景， 将这些知识应用于新的诊断和治疗方法。 虽然美国科学家在推进该领域方面发挥了突出作用， 由于先天性错误，其他国家的许多科学家正在做出非常 重要的贡献，例如这是一个真正的国际 发展领域。 与爆炸性增长的同时， 了解分子机制，许多新的遗传代谢 疾病正在被描述。 现有治疗的成功 策略导致受影响患者的生存时间更长， 认识到以前未预料到的并发症。 鼓励 年轻的新研究人员参与这一令人兴奋的机会， 科学和临床信息的交流是必不可少的， 在这一领域继续取得进展。

Inherited metabolic disorders are now recognized as the underlying basis of an ever increasing variety of sever clinical diseases which interfere with mental development and diverse ophthalmological, neuromuscular, cardiac, pulmonary, hepatic, renal, arthritic, and diabetic manifestations. It is critical for as many US investigators as possible to participate in this forthcoming International Congress because of unparalleled recent advances in understanding the molecular basis of inherited metabolic disorders and exciting prospects for innumerable applications of this knowledge to new methods of diagnosis and treatment. While US scientist have played a prominent role in advancing the field of inborn errors, many scientists in other countries are making very important contributions, such as that this is truly an international field of development. Concurrent with the explosive growth of understanding of molecular mechanisms, many new inherited metabolic disorders are being described. The success of established treatment strategies has led to longer survival of affected patients and recognition of previously unanticipated complications. Encouragement of participation by young new investigators in this exciting opportunity for exchange of scientific and clinical information is essential to sustaining future progress in this field.